Apolipoprotein (apo) B, the critical structural protein of the atherogenic lipoproteins, has two
major isoforms: apoB48 and apoB100. ApoB48 is found in chylomicrons and chylomicron …

Atherosclerosis is responsible for large cardiovascular mortality in many countries globally. It
has been shown over the last decades that the reduction of atherosclerotic progression is a …

Lipid accumulation in the arterial wall is a crucial event in the development of atherosclerotic
lesions. Circulating low-density lipoprotein (LDL) is the major source of lipids that …

The ageing of the global population calls for a better understanding of age-related metabolic
consequences. Here we report the effects of age, sex and menopause on serum metabolites …

Background The causal relationship between low-density lipoprotein (LDL) and
atherosclerotic cardiovascular disease (CVD) has been firmly substantiated. LDL consists of …

OBJECTIVE: Small, dense low-density lipoprotein (sdLDL) and small-sized high-density
lipoprotein (HDL) particles are established risk factors for ischemic heart disease. However …

Low-density-lipoprotein cholesterol (LDL-c) guides lipid-lowering therapy, although other
lipid parameters could better reflect cardiovascular disease (CVD) risk. Discordance …

Background Small dense low-density lipoprotein cholesterol (sdLDL-C) concentration was
useful in the assessment of the presence of cardiovascular diseases (CVD) and its severity …

Context: The ratio of low-density lipoprotein cholesterol to apolipoprotein-B (LDL-C/apoB)
conventionally represents an alternative index of LDL particle size. Objective: This study was …

Introduction Emerging evidence has suggested that lipid metabolism is correlated with
Parkinson's disease (PD) onset and progression. However, the effect of lipid metabolism on …